文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

关于眼部药代动力学的全面见解。

A comprehensive insight on ocular pharmacokinetics.

作者信息

Agrahari Vibhuti, Mandal Abhirup, Agrahari Vivek, Trinh Hoang M, Joseph Mary, Ray Animikh, Hadji Hicheme, Mitra Ranjana, Pal Dhananjay, Mitra Ashim K

机构信息

Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO, 64108, USA.

Bayer HealthCare LLC, Shawnee, KS, 66216, USA.

出版信息

Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2.


DOI:10.1007/s13346-016-0339-2
PMID:27798766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5319401/
Abstract

The eye is a distinctive organ with protective anatomy and physiology. Several pharmacokinetics compartment models of ocular drug delivery have been developed for describing the absorption, distribution, and elimination of ocular drugs in the eye. Determining pharmacokinetics parameters in ocular tissues is a major challenge because of the complex anatomy and dynamic physiological barrier of the eye. In this review, pharmacokinetics of these compartments exploring different drugs, delivery systems, and routes of administration is discussed including factors affecting intraocular bioavailability. Factors such as precorneal fluid drainage, drug binding to tear proteins, systemic drug absorption, corneal factors, melanin binding, and drug metabolism render ocular delivery challenging and are elaborated in this manuscript. Several compartment models are discussed; these are developed in ocular drug delivery to study the pharmacokinetics parameters. There are several transporters present in both anterior and posterior segments of the eye which play a significant role in ocular pharmacokinetics and are summarized briefly. Moreover, several ocular pharmacokinetics animal models and relevant studies are reviewed and discussed in addition to the pharmacokinetics of various ocular formulations.

摘要

眼睛是一个具有独特解剖结构和生理功能的器官。已经开发了几种眼部药物递送的药代动力学房室模型,用于描述眼部药物在眼内的吸收、分布和消除。由于眼睛复杂的解剖结构和动态生理屏障,确定眼组织中的药代动力学参数是一项重大挑战。在本综述中,讨论了探索不同药物、递送系统和给药途径的这些房室的药代动力学,包括影响眼内生物利用度的因素。角膜前液引流、药物与泪液蛋白结合、全身药物吸收、角膜因素、黑色素结合和药物代谢等因素使眼部给药具有挑战性,本文对此进行了阐述。讨论了几种房室模型;这些模型是在眼部药物递送中开发的,用于研究药代动力学参数。眼的前段和后段都存在几种转运体,它们在眼部药代动力学中起着重要作用,本文对此进行了简要总结。此外,除了各种眼部制剂的药代动力学外,还对几种眼部药代动力学动物模型及相关研究进行了综述和讨论。

相似文献

[1]
A comprehensive insight on ocular pharmacokinetics.

Drug Deliv Transl Res. 2016-12

[2]
Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.

Adv Colloid Interface Sci. 2015-8-14

[3]
The role of xenobiotic transporters in ophthalmic drug delivery.

J Pharm Pharm Sci. 2013

[4]
Physiologically based ocular pharmacokinetic modeling using computational methods.

Drug Discov Today. 2019-7-15

[5]
Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.

Curr Pharm Des. 2016

[6]
Recent advances in ocular drug delivery.

Drug Dev Ind Pharm. 2012-11-16

[7]
Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet?

J Pharm Sci. 2017-9

[8]
Ocular preparations: the formulation approach.

Drug Dev Ind Pharm. 2002-5

[9]
Role of membrane transporters and metabolizing enzymes in ocular drug delivery.

Curr Drug Metab. 2014

[10]
Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.

Curr Drug Metab. 2007-2

引用本文的文献

[1]
A Comprehensive Review of the Role of Rho-Kinase Inhibitors in Corneal Diseases.

Life (Basel). 2025-8-13

[2]
Quasi-3D Mechanistic Model for Predicting Eye Drop Distribution in the Human Tear Film.

Bioengineering (Basel). 2025-7-30

[3]
Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings.

PNAS Nexus. 2025-8-11

[4]
Mathematical Models of Topically and Intravitreally Applied Ranibizumab.

Invest Ophthalmol Vis Sci. 2025-8-1

[5]
Electrospun Nanofiber Composite for Levofloxacin in Ocular Drug Delivery.

Pharm Nanotechnol. 2022

[6]
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.

AAPS PharmSciTech. 2025-7-23

[7]
Emerging innovations in ophthalmic drug delivery for diabetic retinopathy: a translational perspective.

Drug Deliv Transl Res. 2025-7-20

[8]
In-situ gel bases ocular delivery system of Ganciclovir, in-vivo and in-vitro investigation.

BMC Pharmacol Toxicol. 2025-5-13

[9]
Mydriasis mediated by local anesthetics: an unexpected adverse event or new therapeutic indication?

Ther Adv Drug Saf. 2025-4-21

[10]
Topical Ocular Drug Delivery: The Impact of Permeation Enhancers.

Pharmaceutics. 2025-3-31

本文引用的文献

[1]
Transporter effects on cell permeability in drug delivery.

Expert Opin Drug Deliv. 2017-3

[2]
Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits.

Eur J Drug Metab Pharmacokinet. 2017-2

[3]
Prediction of Ocular Drug Distribution from Systemic Blood Circulation.

Mol Pharm. 2016-9-6

[4]
Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats.

Daru. 2015-10-24

[5]
Ocular pharmacology.

J Clin Pharmacol. 2016-5

[6]
A mechanistic pharmacokinetic/pharmacodynamic model of factor D inhibition in cynomolgus monkeys by lampalizumab for the treatment of geographic atrophy.

J Pharmacol Exp Ther. 2015-11

[7]
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONS.

Retina. 2015-12

[8]
Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma.

Invest Ophthalmol Vis Sci. 2015-7

[9]
Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data.

Exp Eye Res. 2015-8

[10]
Undefined role of mucus as a barrier in ocular drug delivery.

Eur J Pharm Biopharm. 2015-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索